The critical early proinflammatory events associated with idiopathic pneumonia syndrome in irradiated murine allogeneic recipients are due to donor T cell infusion and potentiated by cyclophosphamide.

We have hypothesized that lung damage occurring in the peri-bone marrow transplant (BMT) period is critical for the subsequent generation of idiopathic pneumonia syndrome (IPS), a major complication following human BMT. The proinflammatory events induced by a common pre-BMT conditioning regimen, cyclophosphamide (Cytoxan(R)) (Cy) and total body irradiation, were analyzed in a murine BMT model. Electron microscopy indicated that Cy exacerbated irradiation-induced epithelial cell injury as early as day 3 after BMT. Allogenicity was an important contributing factor to lung injury as measured by lung wet and dry weights and decreased specific lung compliance. The most significant pulmonary dysfunction was seen in mice receiving both allogeneic T cells and Cy conditioning. IPS was associated with an influx of T cells, macrophages, and neutrophils early post-BMT. Hydroxyproline levels were not increased, indicating that the injury was not fibrotic early post-BMT. As early as 2 h after chemoradiation, host macrophages increased in number in the lung parenchyma. Continued increases in macrophages occurred if splenic T cells were administered with the donor graft. The expression of costimulatory B7 molecules correlated with macrophage numbers. Frequencies of cells expressing mRNA for the inflammatory proteins TNF-alpha, IL-1beta, and TGFbeta were increased. Cy accelerated the upregulation of TGFbeta and increase in host macrophages. The exacerbation of macrophage activation and severity of IPS was dependent on allogeneic T cells, implicating immune-mediated mechanisms as critical to the outcome of IPS. This demonstration of early injury after BMT indicates the need for very early therapeutic intervention before lung damage becomes profound and irreversible.

[1]  S. Neben,et al.  THE EFFECT OF DONOR T LYMPHOCYTES AND TOTAL‐BODY IRRADIATION ON HEMOPOIETIC ENGRAFTMENT AND PULMONARY TOXICITY FOLLOWING EXPERIMENTAL ALLOGENEIC BONE MARROW TRANSPLANTATION , 1992, Transplantation.

[2]  T. Schall,et al.  Overexpression of RANTES using a recombinant adenovirus vector induces the tissue-directed recruitment of monocytes to the lung. , 1996, Journal of immunology.

[3]  V. Ferrans,et al.  Alveolar macrophage replication. One mechanism for the expansion of the mononuclear phagocyte population in the chronically inflamed lung. , 1984, The Journal of clinical investigation.

[4]  A. Panoskaltsis-Mortari,et al.  In situ hybridization with digoxigenin-labeled RNA probes: facts and artifacts. , 1995, BioTechniques.

[5]  R. Berg Determination of 3- and 4-hydroxyproline. , 1982, Methods in enzymology.

[6]  Mahlon D. Johnson,et al.  Expression of Transforming Growth Factor-β1, -β2, and -β3 mRNA and Protein in the Murine Lung , 1991 .

[7]  N. Schmitz,et al.  Comparison of cyclophosphamide, cytarabine, and etoposide as immunosuppressive agents before allogeneic bone marrow transplantation. , 1988, Blood.

[8]  M. Jordana,et al.  Cytokine expression by neutrophils and macrophages in vivo: endotoxin induces tumor necrosis factor-alpha, macrophage inflammatory protein-2, interleukin-1 beta, and interleukin-6 but not RANTES or transforming growth factor-beta 1 mRNA expression in acute lung inflammation. , 1994, American journal of respiratory cell and molecular biology.

[9]  N. Fausto Multifunctional roles for transforming growth factor-beta 1. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[10]  H. Bachofen,et al.  Pressure-volume curves of air- and liquid-filled excised lungs-surface tension in situ. , 1970, Journal of applied physiology.

[11]  H. Deeg,et al.  Marrow transplantation following escalating doses of fractionated total body irradiation and cyclophosphamide--a phase I trial. , 1992, International journal of radiation oncology, biology, physics.

[12]  J. Overgaard,et al.  Radiotherapy-related lung fibrosis enhanced by tamoxifen. , 1996, Journal of the National Cancer Institute.

[13]  M. Anscher,et al.  Transforming Growth Factor β as a Predictor of Liver and Lung Fibrosis after Autologous Bone Marrow Transplantation for Advanced Breast Cancer , 1993 .

[14]  P. Vassalli,et al.  Pneumopathies of the graft-versus-host reaction. Alveolitis associated with an increased level of tumor necrosis factor mRNA and chronic interstitial pneumonitis. , 1989, Laboratory investigation; a journal of technical methods and pathology.

[15]  D. Remick,et al.  Intratracheal administration of endotoxin and cytokines. IV. The soluble tumor necrosis factor receptor type I inhibits acute inflammation. , 1993, The American journal of pathology.

[16]  A. Fine,et al.  The effect of transforming growth factor-beta on cell proliferation and collagen formation by lung fibroblasts. , 1987, The Journal of biological chemistry.

[17]  G. Steel,et al.  Lung damage after hemithoracic irradiation: dependence on mouse strain. , 1986, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens. , 1990 .

[19]  K. Flanders,et al.  Increased production and immunohistochemical localization of transforming growth factor-beta in idiopathic pulmonary fibrosis. , 1991, American journal of respiratory cell and molecular biology.

[20]  W. Haschek,et al.  Pulmonary fibrosis--a possible mechanism. , 1979, Toxicology and applied pharmacology.

[21]  D. Remick,et al.  Intratracheal administration of endotoxin and cytokines. VII. The soluble interleukin-1 receptor and the soluble tumor necrosis factor receptor II (p80) inhibit acute inflammation. , 1994, Clinical immunology and immunopathology.

[22]  G. Gray,et al.  Coblockade of the LFA1:ICAM and CD28/CTLA4:B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully major histocompatibility complex-disparate donor grafts. , 1995, Blood.

[23]  G. Berry,et al.  A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Lung Rejection Study Group. The International Society for Heart Transplantation. , 1990, The Journal of heart transplantation.

[24]  P. Linsley,et al.  In vivo blockade of CD28/CTLA4: B7/BB1 interaction with CTLA4-Ig reduces lethal murine graft-versus-host disease across the major histocompatibility complex barrier in mice. , 1994, Blood.

[25]  W. Haschek,et al.  Long-term morphologic and biochemical features of experimentally induced lung fibrosis in the mouse. , 1982, Laboratory investigation; a journal of technical methods and pathology.

[26]  R. Raghow Role of transforming growth factor-beta in repair and fibrosis. , 1991, Chest.

[27]  J. Hansen,et al.  Idiopathic Pneumonia Syndrome after Bone Marrow Transplantation , 1993 .

[28]  D. Niewoehner,et al.  Bleomycin-induced changes in pulmonary microvascular albumin permeability and extravascular albumin space. , 1983, The American review of respiratory disease.

[29]  H. Moses,et al.  Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta , 1987, Journal of Experimental Medicine.

[30]  T. Colby,et al.  Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[31]  R. Schwartz Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy , 1992, Cell.

[32]  J. Lazo,et al.  Early increases in pulmonary mRNA encoding procollagens and transforming growth factor-beta in mice sensitive to cyclophosphamide-induced pulmonary fibrosis. , 1989, The Journal of pharmacology and experimental therapeutics.

[33]  M. Sporn,et al.  The Transforming Growth Factor-βs , 1991 .

[34]  R. Berg [17] Determination of 3- and 4-hydroxyproline , 1982 .

[35]  W. Lehmacher,et al.  Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation. , 1990, Blood.

[36]  J M Simpson,et al.  Simple method of estimating severity of pulmonary fibrosis on a numerical scale. , 1988, Journal of clinical pathology.

[37]  H. Witschi,et al.  Acute respiratory failure induced by bleomycin and hyperoxia: pulmonary edema, cell kinetics, and morphology. , 1987, Toxicology and applied pharmacology.

[38]  C. Song,et al.  A correlation between conditioning and engraftment in recipients of MHC-mismatched T cell-depleted murine bone marrow transplants. , 1985, Journal of immunology.

[39]  Brown,et al.  Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2-incompatible transplanted SCID mice. , 1994, Blood.

[40]  A. Pearson,et al.  Radiation effects on mouse incisor teeth following whole-body doses of up to 16 gray. , 1981, International journal of radiation biology and related studies in physics, chemistry, and medicine.

[41]  N. Tarbell,et al.  Dose-limiting complications from upper half body irradiation in C3H mice. , 1988, International journal of radiation oncology, biology, physics.

[42]  J. Crawford,et al.  An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. , 1996, Blood.

[43]  B. Corrin,et al.  Immunohistochemical localization of transforming growth factor‐β1 in the lungs of patients with systemic sclerosis, cryptogenic fibrosing alveolitis and other lung disorders , 1994, Histopathology.

[44]  H. Reynolds,et al.  Cyclophosphamide modulation of bronchoalveolar cellular populations and macrophage oxidative metabolism. Possible mechanisms of pulmonary pharmacotoxicity. , 1986, The American review of respiratory disease.

[45]  L. de Leij,et al.  Expression of class II major histocompatibility complex antigens on alveolar epithelium in interstitial lung disease: relevance to pathogenesis of idiopathic pulmonary fibrosis. , 1987, Journal of clinical pathology.

[46]  C. C. Morse,et al.  Pulmonary toxicity of cyclophosphamide: a 1-year study. , 1985, Experimental and molecular pathology.

[47]  W. Woods,et al.  Cyclophosphamide & total body irradiation versus busulfan & cyclophosphamide: A randomized comparison of 2 conditioning regimens in autologous bone marrow transplantation for acute myeloid leukemia , 1994 .

[48]  N. Mantel Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.

[49]  A. Rimm,et al.  Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors. , 1986, Annals of internal medicine.

[50]  J. Bluestone,et al.  Nonmitogenic anti-CD3F(ab')2 fragments inhibit lethal murine graft-versus-host disease induced across the major histocompatibility barrier. , 1993, Journal of immunology.

[51]  M. Sporn,et al.  The Transforming Growth Factor‐Betas: Past, Present, and Future , 1990, Annals of the New York Academy of Sciences.

[52]  J. Curtis,et al.  Requirement of CD4-positive T cells for cellular recruitment to the lungs of mice in response to a particulate intratracheal antigen. , 1991, The Journal of clinical investigation.

[53]  A. Sharpe,et al.  Infusion of anti-B7.1 (CD80) and anti-B7.2 (CD86) monoclonal antibodies inhibits murine graft-versus-host disease lethality in part via direct effects on CD4+ and CD8+ T cells. , 1996, Journal of immunology.

[54]  E. Kovacs,et al.  Transforming Growth Factor-β Production by Lung Macrophages and Fibroblasts , 1991 .

[55]  M. Anscher,et al.  Changes in plasma transforming growth factor beta in response to high-dose chemotherapy for stage II breast cancer: possible implications for the prevention of hepatic veno-occlusive disease and pulmonary drug toxicity. , 1995, Bone marrow transplantation.

[56]  L M Wakefield,et al.  Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[57]  J. Rosenbloom,et al.  Cytokine networks in the regulation of inflammation and fibrosis in the lung. , 1990, Chest.

[58]  W. Woods,et al.  Randomized comparison of cyclophosphamide-total body irradiation versus busulfan-cyclophosphamide conditioning in autologous bone marrow transplantation for acute myeloid leukemia. , 1995, International journal of radiation oncology, biology, physics.

[59]  D. Niewoehner,et al.  Solute conductance of blood-gas barrier in hamsters exposed to hyperoxia. , 1986, Journal of applied physiology.

[60]  M. J. Evans,et al.  Type II cell proliferation related to migration of inflammatory cells into the lung. , 1986, Experimental and molecular pathology.